Rudolf Widmann
Department of Management
AFFiRiS AG
Austria
Biography
Rudolf Widmann is the Chief Executive Officer and Chairman of the Board at AOP Orphan. In 1991, he entered the private sector and began his career in quality management in IMMUNO. Two years later, he joined Wellcome Austria Pharma, where he worked as Head of Medical Services until the company was taken over by Glaxo. In the new company Glaxo-Wellcome, he was active in the Business Unit Hospital as Senior Medical Marketing Adviser. It was during his time in the international pharmaceutical industry that he realized that the large companies were not concentrating on rare diseases and that patients were often being left stranded. This ultimately led to him founding AOP Orphan in 1996, where he is both owner and CEO.
Research Interest
Rare diseases
